Polypeptides having β-1,4-GalNAc transferase activity
AssigneeNational Research Council of Canada
InventorsMichel Gilbert, Warren W. Wakarchuk
Life of this patent
Estimating the term…
Abstract
This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an α2,3- and an α2,8-activity. A β1,4-GalNAc transferase and a β1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
Claims5
An isolated or recombinantly produced polypeptide comprising a polypeptide having β1,4-N-acetygalactosaminyl (GalNAc) transferase activity, wherein the β1,4-GalNAc transferase polypeptide comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:17.
Dependencies are inferred from the claim text.